Autopsy report · NCT03794570

BFR Therapy After ACL Reconstruction

“Investigator separated from institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Steadman Philippon Research Institute

Sponsor type

University, hospital or other

Conditions

ACL Injury; Quadriceps Muscle Atrophy

Interventions

Blood flow restriction therapy - with Delfi Personalized Tourniquet System; Sham blood flow restriction therapy - with Delfi Personalized Tourniquet System

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
  “Investigator Left Institution” (89% match in meaning)
• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (86% match in meaning)
• Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty
  “Responsible Investigator left institution” (85% match in meaning)
• Dupilumab Phase 4 Study
  “Investigator moved from institution.” (84% match in meaning)
• Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations
  “Investigator departed from institution” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.